全球畜牧药物市场 – 行业趋势及 2029 年预测

市场分析和规模

近年来，动物家畜药品市场预计在预测期内将快速增长。动物药品市场由生产用于治疗动物疾病和/或改善动物性能和健康的兽药的实体（组织、个体经营者和合伙企业）销售兽药和提供相关服务组成。生产兽药（如兽医疫苗、兽医抗生素和其他兽药）以及医用饲料添加剂和营养饲料添加剂的机构构成动物药品行业。兽药、饲料添加剂以及家畜和伴侣动物药品是最常见的动物药品类型。

Data Bridge Market Research 分析称，2021 年动物牲畜药物市场价值为 339.39 亿美元，预计到 2029 年将达到 516.9 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 5.40%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

市场定义

除家禽外，牲畜是指饲养的反刍动物和家畜。牛、山羊、绵羊、驴、猪、马和其他动物是这一类中最常见的成员，但其他地区的农业中可能以不同的动物为主。世界上最大的牲畜群是牛（牛属）。绵羊是最早被驯养的动物之一。

报告范围和市场细分

Animal Livestock Drugs Market Dynamics

Drivers

• Increasing prevalence of zoonotic and food-borne diseases

The market is mostly driven by an increase in the global prevalence of zoonotic and food-borne diseases and a major increase in demand for protein diet. Companies are racing to develop new vaccinations and medications in response to this extraordinary spike in disease prevalence. Because of the increasing demand, there has been an increase in the number of companies making regular efforts to control pathogen contamination concerns and food-borne diseases, which is helping to drive market expansion.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of animal livestock drugs market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the animal livestock drugs market. Additionally, increasing penetration of pet insurance and surging demand for online veterinary pharmacies will expand the animal livestock drugs market.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the animal livestock drugs market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate. 

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the animal livestock drugs market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the animal drugs will obstruct the growth rate of the market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the animal livestock drugs market. Additionally, strict regulatory policies and lack of awareness among people will restrain and further impede the growth rate of the market during the forecast period of 2022-2029.

This animal livestock drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the animal livestock drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Animal livestock drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Animal Livestock Drugs Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations had imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The animal livestock drugs market was hampered by the supply chain slowness. However, now that COVID-19 vaccines are readily available, numerous authorities are trying to assure that life-saving medications and vaccines are supplied without interruption. As a result, the market is projected to stabilize in the future.

Global Animal Livestock Drugs Market Scope

The animal livestock drugs market is segmented on the basis of type, product, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Cattle
• Sheep
• Pigs
• Goats
• Horses
• Others

Product

• Drugs
• Antiparasitic
• Anti-inflammatory
• Anti-infectives
• Vaccines
• Modified Live Vaccines [MLV]
• Killed Inactivated Vaccines
• Medicated Feed Additives
• Antibiotics
• Vitamins
• Amino Acids
• Enzymes
• Antioxidants
• Prebiotics and Probiotics
• Minerals

End-Users

• Veterinary Hospitals
• Veterinary Specialty Clinics
• Others

Distribution Channel

• Veterinary Hospital Pharmacy
• Retail Pharmacy
• Veterinary Research Institute
• Others

Animal Livestock Drugs Market Regional Analysis/Insights

The animal livestock drugs market is analysed and market size insights and trends are provided by country, type, product, end-users and distribution channel as referenced above.

The countries covered in the animal livestock drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

北美在畜牧药物市场占据主导地位，因为该地区对研究活动的投资水平不断提高，医疗保健支出不断增加。此外，主要关键参与者的存在将进一步推动该地区市场的增长率。

由于亚太地区政府的宣传活动不断增多，预计该地区在 2022 年至 2029 年的预测期内将实现增长。此外，医疗基础设施的发展和仿制药数量的激增将进一步推动该地区市场的增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和畜牧药品市场份额分析

动物牲畜药物市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对动物牲畜药物市场的关注有关。

动物牲畜药物市场的一些主要参与者包括：

• 赛诺菲（法国）
• F. Hoffmann-La Roche Ltd.（瑞士）
• Mallinckrodt（美国）
• Elanco (美国)
• 勃林格殷格翰国际有限公司（德国）
• 葛兰素史克公司 (英国)
• 诺华公司（瑞士）
• 拜耳公司（德国）
• 礼来公司 (美国)
• 默克公司（美国）
• 阿斯利康（英国）
• 强生私人有限公司（美国）
• 维克（法国）
• Vetoquinol（法国）
• 硕腾 (美国)
• Ceva (法国)
• Bimeda, Inc.（美国）
• Dechra Pharmaceuticals PLC（英国）

SKU-55678